alexa New Challenges In Glycemic Management For Patients With Diabetes Mellitus And Chronic Kidney Disease | 61281
ISSN: 2155-6156

Journal of Diabetes & Metabolism
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

14th International Conference and Exhibition on Targeting Diabetes and Novel Therapeutics

Mark E Williams
Harvard Medical School, USA
Posters & Accepted Abstracts: J Diabetes Metab
DOI: 10.4172/2155-6156.C1.058
Abstract
The management of hyperglycemia in patients with chronic kidney disease (CKD) is complex and the goals and methods regarding glycemic control in CKD are not clearly defined. Although aggressive glycemic control seems to be advantageous in early stages of diabetic kidney disease, outcome data supporting tight glycemic control in patients with advanced CKD or end-stage kidney disease (ESKD) are lacking. Challenges in the management of patients with advanced CKD or ESKD include a growing array of available oral and injectable therapies, therapeutic inertia, monitoring difficulties and the complexity of combining various treatment regimens. This presentation will review the known alterations in glucose homeostasis that occur in kidney impairment, updated views on the value of glycemic control and issues with its determination, and recent data on approaches to monitoring glycemic control. Hypoglycemia, more frequent in diabetic CKD patients, will be analyzed. Treatment options for patients with diabetes and CKD or ESKD will be addressed including both the insulin and non-insulin agents that are currently available along with their indications and contraindications. The presentation will provide information to help clinicians and researchers in decision-making in order to reach individualized glycemic goals using appropriate therapy for patients with CKD or ESKD.
Biography

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7